Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins
- PMID: 3142012
- DOI: 10.1093/clinids/10.4.752
Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins
Abstract
The kinetic interactions of the beta-lactamase from Enterobacter cloacae 908 R with ceftriaxone, cefotaxime, and ceftazidime have been examined in detail. With all of these cephalosporins, there is an initial rapid reaction involving opening of the beta-lactam that then decreases to a slower steady-state rate (kss) of beta-lactam hydrolysis (at 37 degrees C: ceftriaxone, kss = 0.044 s-1; cefotaxime, kss = 0.033 s-1; ceftazidime, kss = 0.011 s-1). More than stoichiometric quantities of beta-lactam are cleaved during the rapid phase, during which there is accumulation of a transiently stable cephalosporin-enzyme complex whose rate of breakdown is slower than the overall rate of hydrolysis. Qualitatively similar behavior is observed with the E. cloacae M6300 beta-lactamase. These observations eliminate the possibility that the reaction follows a simple linear kinetic scheme. A branched kinetic scheme in which an initially formed acyl intermediate partitions between deacylation and elimination of the 3' substituent is proposed to explain the data. Investigations of the interaction of ceftriaxone with the chromosomally encoded beta-lactamases from Citrobacter freundii, Providencia rettgeri, Morganella morganii, Pseudomonas aeruginosa, and Escherichia coli show that the partitioning behavior of E. cloacae beta-lactamases is atypical. All of the data, however, clearly demonstrate that it is a physical impossibility for cephalosporin trapping to contribute to bacterial resistance phenotypes.
Similar articles
-
Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.Drugs Exp Clin Res. 1989;15(1):1-10. Drugs Exp Clin Res. 1989. PMID: 2663406
-
On the kinetic interaction between ceftriaxone and some beta-lactamases.Drugs Exp Clin Res. 1988;14(1):25-30. Drugs Exp Clin Res. 1988. PMID: 3260552
-
Inhibitory activity of cefpiramide on beta-lactamase.Chemotherapy. 1985;31(3):200-3. doi: 10.1159/000238336. Chemotherapy. 1985. PMID: 3888544
-
The spread of CTX-M-type extended-spectrum beta-lactamases.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:33-41. doi: 10.1111/j.1469-0691.2007.01867.x. Clin Microbiol Infect. 2008. PMID: 18154526 Review.
-
Contribution of chromosomal beta-lactamases to beta-lactam resistance in enterobacteria.Rev Infect Dis. 1986 Jul-Aug;8 Suppl 3:S292-304. doi: 10.1093/clinids/8.supplement_3.s292. Rev Infect Dis. 1986. PMID: 3529322 Review.
Cited by
-
The kinetics of non-stoichiometric bursts of beta-lactam hydrolysis catalysed by class C beta-lactamases.Biochem J. 1993 Oct 1;295 ( Pt 1)(Pt 1):295-304. doi: 10.1042/bj2950295. Biochem J. 1993. PMID: 8216231 Free PMC article.
-
Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715.Biochem J. 1994 Nov 1;303 ( Pt 3)(Pt 3):825-30. doi: 10.1042/bj3030825. Biochem J. 1994. PMID: 7980451 Free PMC article.
-
In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.Antimicrob Agents Chemother. 2001 Mar;45(3):825-36. doi: 10.1128/AAC.45.3.825-836.2001. Antimicrob Agents Chemother. 2001. PMID: 11181368 Free PMC article.
-
Resistance to third generation cephalosporins: the current situation.Infection. 1989 Sep-Oct;17(5):333-7. doi: 10.1007/BF01650724. Infection. 1989. PMID: 2689351 Review.
-
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae.Antimicrob Agents Chemother. 1991 Jan;35(1):73-8. doi: 10.1128/AAC.35.1.73. Antimicrob Agents Chemother. 1991. PMID: 2014984 Free PMC article.